ARTICLE | Company News
Qiagen, French National Institute of Health and Medical Research (Inserm) deal
January 14, 2013 8:00 AM UTC
Inserm and its Inserm Transfert S.A. subsidiary granted Qiagen's Qiagen Marseille subsidiary worldwide rights to IP around mutations in the heat shock 105 kDa protein 1 ( HspH1; Hsp105; Hsp110). Qia...